Soluble mannose receptor CD206 and von Willebrand factor are early biomarkers to identify patients at risk for severe or necrotizing acute pancreatitis.

Philipp A ReukenJonathan F BrozatStefanie QuickertOluwatomi Ibidapo-ObeJohanna ReißingAnika FranzSven StengelUlf K-M TeichgräberMichael KiehntopfChristian TrautweinAndreas StallmachAlexander KochKaren Schmidt

Published in: Journal of intensive care (2022)

sCD206 identifies patients at risk of severe AP at earlier timepoints than routine markers of inflammation and coagulation. Prospective studies are needed to investigate whether incorporating early or repeated measurements into the existing scoring system will better identify patients at increased risk for complications of AP.

Keyphrases

end stage renal disease
transcription factor
ejection fraction
newly diagnosed
early onset
genome wide
risk factors
drug induced
binding protein
nk cells